Tapewire

NYSE · USD

CVS

CVS HEALTH Corp

Export transactions ↓
Tapewire entity
2884
SEC CIK
0000064803
Parsed reports
1,748

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 26, 2026 Filed Jun 29, 2026 19:11 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
Tax withholdingCommon Stock (Restricted) 454 $90.98 $41,304.92
Disclosure

SEC source: 0000064803-26-000092 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,606

F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.

Read SEC document
May 31, 2026 Filed Jun 1, 2026 21:02 UTC
Newman BrianEVP, Chief Financial Officer
Tax withholdingCommon Stock 2,478 $90.98 $225,448.44
Disclosure

SEC source: 0000064803-26-000088 · form4.xml · nonDerivative · entry 1

Newman Brian · CIK 0001788049 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,008

F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.

Read SEC document
May 31, 2026 Filed Jun 1, 2026 21:00 UTC
Compton-Phillips AmyEVP, Chief Medical Officer
Tax withholdingCommon Stock 7,618 $90.98 $693,085.64
Disclosure

SEC source: 0000064803-26-000086 · form4.xml · nonDerivative · entry 1

Compton-Phillips Amy · CIK 0001741492 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,557

F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.

Read SEC document
May 21, 2026 Filed May 21, 2026 21:43 UTC SaleCash-Settled Swaps · Derivative 378,000 $93.31 Strike: $58.29 $35,271,558.00
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · derivative · entry 8

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 0

Underlying: Common Stock · 378,000 shares

Expires 2027-09-16

F10 · security: These cash-settled swaps reference shares of the Issuer's common stock (the "Swaps") and are held for the account of the GO Fund.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F11 · ownership.nature: The GO Fund is the record holder of the Swaps. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to the GO Fund. The Reporting Person shares voting and dispositive power over the Swaps held by the GO Fund and may be deemed to beneficially own such Swaps.

Read SEC document
May 21, 2026 Filed May 21, 2026 21:43 UTC SaleCommon Stock 370,462 $93.45 $34,619,007.07
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 7

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 4,824,799

F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F9 · price: This price reflects the weighted average price for open-market sales of Shares on May 21, 2026 within a $1.00 range. The actual prices for these transactions range from $93.125 to $93.83, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Read SEC document
May 21, 2026 Filed May 22, 2026 21:39 UTC Disposition to issuerCommon Stock 1,563 $93.50 $146,142.06
Disclosure

SEC source: 0000064803-26-000084 · form4.xml · nonDerivative · entry 2

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,513

F2 · kind: Represents weighted average purchase price of 93.775 per share.

Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC SaleCommon Stock 800 $96.28 $77,025.52
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 6

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 5,195,261

F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F8 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $96.25 to $96.34, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC SaleCommon Stock 66,881 $95.67 $6,398,204.31
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 5

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 5,196,061

F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F7 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $95.25 to $96.21, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC SaleCommon Stock 152,691 $94.81 $14,476,038.22
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 4

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 5,262,942

F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F6 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $94.25 to $95.245, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC SaleCommon Stock 797,628 $93.48 $74,559,553.50
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 3

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 5,415,633

F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F5 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $93.25 to $94.19, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Read SEC document
May 20, 2026 Filed May 22, 2026 21:39 UTC Disposition to issuerCommon Stock 30,437 $93.78 $2,854,229.68
Disclosure

SEC source: 0000064803-26-000084 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,076

F1 · kind: Represents weighted average purchase price for this group of purchases, which occurred on the same day. Multiple purchases were conducted, with prices ranging between $93.50 and $94.01 per share.

Read SEC document
May 19, 2026 Filed May 21, 2026 21:43 UTC SaleCommon Stock 151 $95.18 $14,372.18
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 2

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 6,213,261

F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Read SEC document
May 19, 2026 Filed May 21, 2026 21:43 UTC SaleCommon Stock 1,983,387 $94.45 $187,326,935.38
Disclosure

SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 1

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Glenview Investment Funds

Disclosed balance after: 6,213,412

F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F2 · price: This price reflects the weighted average price for open-market sales of Shares on May 19, 2026 within a $1.00 range. The actual prices for these transactions range from $94.18 to $95.175, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:04 UTC GrantDeferred Stock Units · Derivative 1,930.0051 $97.15 Strike: $0.00 $187,500.00
Disclosure

SEC source: 0000064803-26-000058 · form4.xml · derivative · entry 1

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,147.6418

Underlying: Common Stock · 1,930.0051 shares

Expires not disclosed

F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person.

F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:06 UTC GrantDeferred Stock Units · Derivative 1,447.5039 $97.15 Strike: $0.00 $140,625.00
Disclosure

SEC source: 0000064803-26-000060 · form4.xml · derivative · entry 1

Shulman Douglas H. · CIK 0001726926 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,447.5039

Underlying: Common Stock · 1,447.5039 shares

Expires not disclosed

F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:07 UTC GrantCommon Stock 1,544 $97.15 $149,999.60
Disclosure

SEC source: 0000064803-26-000062 · form4.xml · nonDerivative · entry 1

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,316

F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:08 UTC GrantDeferred Stock Units · Derivative 1,544.0041 $97.15 Strike: $0.00 $150,000.00
Disclosure

SEC source: 0000064803-26-000064 · form4.xml · derivative · entry 1

Finucane Anne A. · CIK 0001511491 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,355.0364

Underlying: Common Stock · 1,544.0041 shares

Expires not disclosed

F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:10 UTC GrantDeferred Stock Units · Derivative 1,447.5039 $97.15 Strike: $0.00 $140,625.00
Disclosure

SEC source: 0000064803-26-000066 · form4.xml · derivative · entry 1

DECOUDREAUX ALECIA A · CIK 0001233354 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,181.8314

Underlying: Common Stock · 1,447.5039 shares

Expires not disclosed

F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:11 UTC GrantCommon Stock 1,447 $97.15 $140,576.05
Disclosure

SEC source: 0000064803-26-000068 · form4.xml · nonDerivative · entry 1

SANSONE GUY P · CIK 0001301446 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,106.355

F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:12 UTC GrantCommon Stock 1,447 $97.15 $140,576.05
Disclosure

SEC source: 0000064803-26-000070 · form4.xml · nonDerivative · entry 1

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,376

F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:14 UTC GrantCommon Stock 1,447 $97.15 $140,576.05
Disclosure

SEC source: 0000064803-26-000072 · form4.xml · nonDerivative · entry 1

KIRBY J SCOTT · CIK 0001249555 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,434

F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:19 UTC GrantCommon Stock 2,058 $97.15 $199,934.70
Disclosure

SEC source: 0000064803-26-000074 · form4.xml · nonDerivative · entry 1

Balser Jeffrey R. · CIK 0001751633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,717

F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:20 UTC GrantCommon Stock 1,563 $97.15 $151,845.45
Disclosure

SEC source: 0000064803-26-000076 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,513

F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:23 UTC GrantDeferred Stock Units · Derivative 1,737.0046 $97.15 Strike: $0.00 $168,750.00
Disclosure

SEC source: 0000064803-26-000078 · form4.xml · derivative · entry 1

Mahoney Michael F · CIK 0001533022 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,428.8174

Underlying: Common Stock · 1,737.0046 shares

Expires not disclosed

F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

Read SEC document
May 14, 2026 Filed May 15, 2026 21:25 UTC GrantDeferred Stock Units · Derivative 1,447.5039 $97.15 Strike: $0.00 $140,625.00
Disclosure

SEC source: 0000064803-26-000080 · form4.xml · derivative · entry 1

Gallina John E · CIK 0001433032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,447.5039

Underlying: Common Stock · 1,447.5039 shares

Expires not disclosed

F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:27 UTC
Mandadi TilakEVP, Chief Exp & Tech Officer
SaleCommon Stock 69,551 $89.58 $6,230,378.58
Disclosure

SEC source: 0000064803-26-000056 · form4.xml · nonDerivative · entry 1

Mandadi Tilak · CIK 0001872827 · EVP, Chief Exp & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,133

F1 · price: All shares sold at an Average price between $89.30 and $89.81.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:49 UTC
CAPOZZI HEIDI BEVP and Chief People Officer
Tax withholdingCommon Stock 1,334 $72.49 $96,701.66
Disclosure

SEC source: 0000064803-26-000035 · form4.xml · nonDerivative · entry 2

CAPOZZI HEIDI B · CIK 0001661608 · EVP and Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,023

F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:51 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
Tax withholdingCommon Stock 3,262 $72.49 $236,462.38
Disclosure

SEC source: 0000064803-26-000036 · form4.xml · nonDerivative · entry 2

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,457

F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:52 UTC
Joyner J. DavidDirector · President, CEO and Chair
Tax withholdingCommon Stock 8,029 $72.49 $582,022.21
Disclosure

SEC source: 0000064803-26-000038 · form4.xml · nonDerivative · entry 2

Joyner J. David · CIK 0001515598 · Director · President, CEO and Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,349

F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:54 UTC
Khichi Samrat S.EVP, CPO and General Counsel
Tax withholdingCommon Stock 3,541 $72.49 $256,687.09
Disclosure

SEC source: 0000064803-26-000039 · form4.xml · nonDerivative · entry 2

Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,421

F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:55 UTC
Mandadi TilakEVP, Chief Exp & Tech Officer
Tax withholdingCommon Stock 3,634 $72.49 $263,428.66
Disclosure

SEC source: 0000064803-26-000040 · form4.xml · nonDerivative · entry 2

Mandadi Tilak · CIK 0001872827 · EVP, Chief Exp & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,684

F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:56 UTC
Nelson Steven HEVP and President, Aetna
Tax withholdingCommon Stock 2,432 $72.49 $176,295.68
Disclosure

SEC source: 0000064803-26-000041 · form4.xml · nonDerivative · entry 2

Nelson Steven H · CIK 0001320490 · EVP and President, Aetna

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,900

F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:58 UTC
Shah Prem SEVP and Group President
Tax withholdingCommon Stock 1,484 $72.49 $107,575.16
Disclosure

SEC source: 0000064803-26-000043 · form4.xml · nonDerivative · entry 2

Shah Prem S · CIK 0001900910 · EVP and Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,356.0985

F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:49 UTC
CAPOZZI HEIDI BEVP and Chief People Officer
GrantStock Option · Derivative 64,670 $71.82 Strike: $71.82 $4,644,599.40
Disclosure

SEC source: 0000064803-26-000035 · form4.xml · derivative · entry 3

CAPOZZI HEIDI B · CIK 0001661608 · EVP and Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,670

Underlying: Common Stock · 64,670 shares

Expires 2036-03-31

F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:49 UTC
CAPOZZI HEIDI BEVP and Chief People Officer
GrantCommon Stock (Restricted) 10,025 $71.82 $719,995.50
Disclosure

SEC source: 0000064803-26-000035 · form4.xml · nonDerivative · entry 1

CAPOZZI HEIDI B · CIK 0001661608 · EVP and Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,450

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:51 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
GrantStock Option · Derivative 11,976 $71.82 Strike: $71.82 $860,116.32
Disclosure

SEC source: 0000064803-26-000036 · form4.xml · derivative · entry 3

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,976

Underlying: Common Stock · 11,976 shares

Expires 2036-03-31

F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:51 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
GrantCommon Stock (Restricted) 11,138 $71.82 $799,931.16
Disclosure

SEC source: 0000064803-26-000036 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,539

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:52 UTC
Compton-Phillips AmyEVP, Chief Medical Officer
GrantStock Option · Derivative 35,928 $71.82 Strike: $71.82 $2,580,348.96
Disclosure

SEC source: 0000064803-26-000037 · form4.xml · derivative · entry 2

Compton-Phillips Amy · CIK 0001741492 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,928

Underlying: Common Stock · 35,928 shares

Expires 2036-03-31

F2 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:52 UTC
Compton-Phillips AmyEVP, Chief Medical Officer
GrantCommon Stock (RSUs) 5,569 $71.82 $399,965.58
Disclosure

SEC source: 0000064803-26-000037 · form4.xml · nonDerivative · entry 1

Compton-Phillips Amy · CIK 0001741492 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,660

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:52 UTC
Joyner J. DavidDirector · President, CEO and Chair
GrantCommon Stock (RSUs) 86,326 $71.82 $6,199,933.32
Disclosure

SEC source: 0000064803-26-000038 · form4.xml · nonDerivative · entry 1

Joyner J. David · CIK 0001515598 · Director · President, CEO and Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,860

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:54 UTC
Khichi Samrat S.EVP, CPO and General Counsel
GrantStock Option · Derivative 80,838 $71.82 Strike: $71.82 $5,805,785.16
Disclosure

SEC source: 0000064803-26-000039 · form4.xml · derivative · entry 3

Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,838

Underlying: Common Stock · 80,838 shares

Expires 2036-03-31

F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:54 UTC
Khichi Samrat S.EVP, CPO and General Counsel
GrantCommon Stock (Restricted) 12,531 $71.82 $899,976.42
Disclosure

SEC source: 0000064803-26-000039 · form4.xml · nonDerivative · entry 1

Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,139

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:55 UTC
Mandadi TilakEVP, Chief Exp & Tech Officer
GrantStock Option · Derivative 143,712 $71.82 Strike: $71.82 $10,321,395.84
Disclosure

SEC source: 0000064803-26-000040 · form4.xml · derivative · entry 3

Mandadi Tilak · CIK 0001872827 · EVP, Chief Exp & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,712

Underlying: Common Stock · 143,712 shares

Expires 2036-03-31

F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:55 UTC
Mandadi TilakEVP, Chief Exp & Tech Officer
GrantCommon Stock (RSUs) 22,277 $71.82 $1,599,934.14
Disclosure

SEC source: 0000064803-26-000040 · form4.xml · nonDerivative · entry 1

Mandadi Tilak · CIK 0001872827 · EVP, Chief Exp & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,543

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:56 UTC
Nelson Steven HEVP and President, Aetna
GrantStock Option · Derivative 143,712 $71.82 Strike: $71.82 $10,321,395.84
Disclosure

SEC source: 0000064803-26-000041 · form4.xml · derivative · entry 3

Nelson Steven H · CIK 0001320490 · EVP and President, Aetna

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,712

Underlying: Common Stock · 143,712 shares

Expires 2036-03-31

F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:56 UTC
Nelson Steven HEVP and President, Aetna
GrantCommon Stock (Restricted) 22,277 $71.82 $1,599,934.14
Disclosure

SEC source: 0000064803-26-000041 · form4.xml · nonDerivative · entry 1

Nelson Steven H · CIK 0001320490 · EVP and President, Aetna

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,606

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:57 UTC
Newman BrianEVP, Chief Financial Officer
GrantStock Option · Derivative 125,748 $71.82 Strike: $71.82 $9,031,221.36
Disclosure

SEC source: 0000064803-26-000042 · form4.xml · derivative · entry 2

Newman Brian · CIK 0001788049 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,748

Underlying: Common Stock · 125,748 shares

Expires 2036-03-31

F2 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:57 UTC
Newman BrianEVP, Chief Financial Officer
GrantCommon Stock (RSUs) 19,493 $71.82 $1,399,987.26
Disclosure

SEC source: 0000064803-26-000042 · form4.xml · nonDerivative · entry 1

Newman Brian · CIK 0001788049 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,354

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:58 UTC
Shah Prem SEVP and Group President
GrantStock Option · Derivative 161,676 $71.82 Strike: $71.82 $11,611,570.32
Disclosure

SEC source: 0000064803-26-000043 · form4.xml · derivative · entry 3

Shah Prem S · CIK 0001900910 · EVP and Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,676

Underlying: Common Stock · 161,676 shares

Expires 2036-03-31

F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:58 UTC
Shah Prem SEVP and Group President
GrantCommon Stock (Restricted) 25,062 $71.82 $1,799,952.84
Disclosure

SEC source: 0000064803-26-000043 · form4.xml · nonDerivative · entry 1

Shah Prem S · CIK 0001900910 · EVP and Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,852

F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.